Agar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.
Agar is a global leader in the distribution and manufacture of electron microscopy consumables. The business was created as the result of an MBO carve out backed by Foresight Group in 2016. Since then, the firm has more than doubled in size under the stewardship of Darren Likely and the Agar management team. Agar has a strong strategic fit with Calibre, providing many synergy benefits. It will enable Calibre to expand their customer base and open up new markets in high growth areas.
Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, with an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth, its global reach extends into over 100 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.
Oaklins Cavendish, based in the UK, acted as advisor to Agar Scientific in this transaction.
Darren Likely
CEO, Agar Scientific Ltd.
Sprechen Sie mit dem Deal-Team
Michael Jewell
Oaklins Cavendish
Relevante Transaktionen
Jeco Energies has sold a significant minority interest to NPM Capital
NPM Capital has acquired a significant minority interest in Jeco Energies. By teaming up with NPM Capital, Jeco Energies is ready for the next step in its remarkable growth trajectory and strengthening its position as the leading industrial energy solutions provider.
Weitere InformationenVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Weitere InformationenGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Weitere Informationen